Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.130 INR | +3,82 % |
|
-0,59 % | +1,49 % |
Resumen de negocios
Número de empleados: 16 167
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Branded Generics
53,8
%
| 30 028 | 51,5 % | 33 597 | 53,8 % | +11,88 % |
Active Pharmaceutical Ingredients
24,4
%
| 15 132 | 26,0 % | 15 217 | 24,4 % | +0,56 % |
Generics
21,2
%
| 12 504 | 21,4 % | 13 255 | 21,2 % | +6,00 % |
Miscellaneous
0,5
%
| 300 | 0,5 % | 298 | 0,5 % | -0,57 % |
Export Incentives
0,1
%
| 302 | 0,5 % | 59 | 0,1 % | -80,34 % |
Sundry Balances Written Back
0,0
%
| 32 | 0,1 % | 17 | 0,0 % | -46,06 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
52,3
%
| 30 112 | 51,7 % | 32 655 | 52,3 % | +8,44 % |
Americas
10,2
%
| 6 707 | 11,5 % | 6 367 | 10,2 % | -5,07 % |
Europe
9,3
%
| 5 439 | 9,3 % | 5 783 | 9,3 % | +6,32 % |
Asia (excluding India)
7,8
%
| 4 615 | 7,9 % | 4 885 | 7,8 % | +5,84 % |
Africa
7,6
%
| 4 754 | 8,2 % | 4 769 | 7,6 % | +0,31 % |
United Kingdom
4,8
%
| 2 597 | 4,5 % | 2 998 | 4,8 % | +15,44 % |
Australasia
4,4
%
| 2 476 | 4,2 % | 2 777 | 4,4 % | +12,17 % |
Commonwealth of Independent States
3,5
%
| 1 598 | 2,7 % | 2 210 | 3,5 % | +38,29 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 68 | 02/04/80 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 16/04/03 |
Chairman | 77 | 31/10/75 | |
Chief Tech/Sci/R&D Officer | 50 | 16/10/23 | |
Chief Investment Officer | - | - | |
Ashok Kumar
CTO | Chief Tech/Sci/R&D Officer | 70 | 06/09/00 |
Anil Pareek
CTO | Chief Tech/Sci/R&D Officer | 67 | 11/09/00 |
Compliance Officer | 64 | 20/09/93 | |
Sanjay Kapadia
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 55 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 77 | 31/10/75 | |
Director/Board Member | 76 | 16/08/11 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 16/04/03 |
Chief Executive Officer | 68 | 02/04/80 | |
Manisha Premnath
BRD | Director/Board Member | 50 | 21/09/14 |
Director/Board Member | 69 | 20/10/22 | |
Director/Board Member | 78 | 29/03/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 253 700 000 | 132 593 199 ( 52,26 %) | 0 | 52,26 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
UNICHEM LABORATORIES LIMITED 52.67% | 37 081 011 | 52.67% | 240 820 772 $ |
LYKA LABS LIMITED 36.34% | 12 024 923 | 36.34% | 15 544 137 $ |
Información de la empresa
Ipca Laboratories Ltd.
125, Kandivli Industrial Estate Kandivili West
400067, Mumbai
+91 22 6647 4444
http://www.ipca.com![Dirección Ipca Laboratories Limited(IPCALAB)](https://cdn.zonebourse.com/static/address/9059018.png)
Ventas por actividad
Ventas por región
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,49 % | 3438,22 M | |
+55,32 % | 815 mil M | |
+44,05 % | 641 mil M | |
-6,75 % | 352 mil M | |
+13,56 % | 314 mil M | |
+10,68 % | 303 mil M | |
+16,57 % | 242 mil M | |
+2,04 % | 224 mil M | |
+13,31 % | 218 mil M | |
+8,48 % | 168 mil M |
- Bolsa de valores
- Acciones
- Acción IPCALAB
- Empresa Ipca Laboratories Limited